AGT
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
AGT; angiotensinogen (serpin peptidase inhibitor, clade A, member 8); ANHU; SERPINA8;
BAG1
BCL2-associated athanogene
BAG1; BCL2-associated athanogene; BAG family molecular chaperone regulator 1; BAG-1; Bcl-2-binding protein; receptor-associated protein, 46-KD; Bcl-2 associating athanogene-1 protein; glucocortoid receptor-associated protein RAP46; HAP; RAP46;
BAG2
BCL2-associated athanogene 2
BAG2; BCL2-associated athanogene 2; BAG family molecular chaperone regulator 2; bcl-2-associated athanogene 2; BAG-family molecular chaperone regulator-2; dJ417I1.2 (BAG-family molecular chaperone regulator 2); BAG-2; dJ417I1.2; KIAA0576; MGC149462;
BAG3
BCL2-associated athanogene 3
BAG3; BCL2-associated athanogene 3; BIS; MFM6; BAG-3; CAIR-1; BAG family molecular chaperone regulator 3; docking protein CAIR-1; BCL2-binding athanogene 3; bcl-2-binding protein Bis;
FCN1
ficolin (collagen/fibrinogen domain containing) 1
FCN1; ficolin (collagen/fibrinogen domain containing) 1; ficolin-1; FCNM; Collagen/fibrinogen domain containing protein 1; Collagen/fibrinogen domain-containing protein 1; FCN1_HUMAN; Ficolin 1; Ficolin A; Ficolin alpha; Ficolin-A; Ficolin-alpha; M ficolin; M-ficolin; OTTHUMP00000022519; ficolin (collagen/fibrinogen domain-containing) 1;
IgM
Immunoglobulin M
Constant region of heavy chain of IgM; Hepatitis B virus receptor binding protein; Ig mu chain C region; IGHM; Immunoglobulin mu chain; Imunoglobulin heavy chain; VH; IgM; Immunoglobulin M; IgMμ; Immunoglobulin Mμ; IgM heavy chain, Immunoglobulin M heavy chain; IgMμheavy chain; Immunoglobulin Mμheavy chain;
KIR2DL1
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
KIR2DL1; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; killer cell immunoglobulin-like receptor 2DL1; 47.11; CD158A; cl 42; nkat1; p58.1; NKAT-1; killer Ig receptor; p58 NK receptor CL-42/47.11; MHC class I NK cell receptor; killer inhibitory receptor 2-2-1; CD158 antigen-like family member A; natural killer-associated transcript 1; p58 NK cell inhibitory receptor NKR-K6; p58.1 MHC class-I-specific NK receptor; p58 killer cell inhibitory receptor KIR-K64; p58 natural killer cell receptor clones CL-42/47.11; NKAT; KIR221; KIR-K64;
KIR2DL3
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
KIR2DL3; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3; killer cell immunoglobulin-like receptor 2DL3; CD158B2; cl 6; nkat2; nkat2a; nkat2b; p58; CD158b; GL183; Killer Cell Immunoglobulin Like Receptor 2DL3; Killer inhibitory receptor CL2 3; KIR023GB; MHC Class I NK Cell Receptor; Natural Killer Associated Transcript 2; p58 Natural Killer Cell Receptor Clone CL6; p58 NK Receptor; p58.2 MHC Class I Specific NK Receptor; NKAT-2; NK-receptor; OTTHUMP00000068619; p58 NK receptor CL-6; killer inhibitory receptor cl 2-3; CD158 antigen-like family member B2; natural kill; NKAT; KIR-K7b; KIR-K7c; KIRCL23; KIR-023GB;
KIR2DL4
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
KIR2DL4; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4; killer cell immunoglobulin-like receptor 2DL4; 15.212; 103AS; CD158D; KIR-103AS; NK cell receptor; killer Ig receptor; CD158 antigen-like family member D; MHC class;
KIR2DS4
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
KIR2DS4; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4; killer cell immunoglobulin-like receptor 2DS4; CD158i; cl 39; KKA3; nkat8; CD158 antigen like family member I; CD158i antigen; CL 17; CL17; CL39; Killer cell immunoglobulin like receptortwo domains short cytoplasmic tail 4; Killer inhibitory receptor 4 1 2; KIR antigen 2DS4; KIR1D; KIR412; MGC120019; MGC125315; MGC125317; MHC class I NK cell receptor; Natural killer associated transcript 8; Natural killer cell inhibitory receptor; NKAT 8; P58 natural killer cell receptor clone CL 39; p58 NK receptor; NKAT-8; OTTHUMP00000199030; p58 NK receptor CL-39/CL-17; killer inhibitory receptor 4-1-2; CD158 antigen-like family member I; natural killer-associated transcript 8; na;
KIR3DL1
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
KIR3DL1; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1; KIR; killer cell immunoglobulin-like receptor 3DL1; AMB11; CD158e1; CD158e1/2; CD158e2; cl 2; cl 11; nkat3; NKB1; NKB1B; CD158 antigen-like family member E; CD158E; CD158e antigen; CL11; CL2; HLA-BW4-specific inhibitory NK cell receptor; killer cell immunoglobulin like receptor; Killer cell immunoglobulin like receptor three domains , short cytoplasmic tail, 1; Killer cell immunoglobulin like receptor three domains long cytoplasmic tail 1; KIR antigen 3DL1; KIR G1; KIR3DS1; Kirl1; Kirl2; Krl1; MGC119726; MGC119728; MGC126589; MGC126591; MHC class I NK cell receptor; Natural killer associated transcript 3; Natural killer cell inhibitory receptor; NK receptor; NK-associated transcript 10; NK-associated transcript 3; NK-associated transcript 3delIg1; NKAT10; p70 killer cell inhibitory receptor; p70 natural killer cell receptor clones CL 2/CL 11; NKAT-3; NK-receptor; OTTHUMP00000068687; OTTHUMP00000068688; OTTHUMP00000081758; killer Ig receptor; p70 NK receptor CL-2/CL-11; p70 ki; KIR3DL1/S1;
LAIR1
leukocyte-associated immunoglobulin-like receptor 1
LAIR1; leukocyte-associated immunoglobulin-like receptor 1; leukocyte associated Ig like receptor 1; CD305; 5133400O11Rik; D7Bwg0421e; hLAIR1; LAIR 1; LAIR-1; LAIR1 protein; LAIR1_HUMAN; Leukocyte associated immunoglobulin like receptor 1; OTTHUMP00000068183; OTTHUMP00000068184; OTTHUMP00000068185; OTTHUMP00000068186; OTTHUMP00000068187; leukocyte-associated Ig-like receptor 1;
LAIR2
leukocyte-associated immunoglobulin-like receptor 2
LAIR2; leukocyte-associated immunoglobulin-like receptor 2; leukocyte associated Ig like receptor 2; CD306; CD306 antigen; LAIR 2; LAIR-2; LAIR2_HUMAN; Leukocyte associated immunoglobulin like receptor 2; MGC71634; OTTHUMP00000068389; OTTHUMP00000068390; leukocyte-associated Ig-like receptor 2; leukocyte-associated Ig-like receptor-2;
LILRB3
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3
LILRB3; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3; leukocyte immunoglobulin-like receptor subfamily B member 3; CD85a; HL9; ILT5; LIR 3; LIR3; CD85 antigen like family member A; CD85a antigen; IL T5; Immunoglobulin like transcript 5; Leukocyte immunoglobulin like receptor 3; Leukocyte immunoglobulin like receptor subfamily B (with TM and ITIM domains) member 3; Leukocyte immunoglobulin like receptor subfamily B member 3; MGC138403; Monocyte inhibitory receptor HL9; PIRB; ILT-5; OTTHUMP00000069587; OTTHUMP00000197712; OTTHUMP00000237014; immunoglobulin-like transcript 5; CD85 antigen-like family member A; leukocyte immunoglobulin-like re; LIR-3;
MGLL
Mgll monoglyceride lipase
MGLL; monoglyceride lipase; monoacylglycerol lipase; Mgl; Magl; AA589436;
NANOG
Nanog homeobox
NANOG; Nanog homeobox; homeobox protein NANOG; ES cell-associated protein 4; homeobox transcription factor Nanog; early embryo specific expression NK family; early embryo specific expression NK-type homeobox protein; ENK; ecat4; 2410002E02Rik;
PGC
progastricsin (pepsinogen C)
progastricsin (pepsinogen C); PEPC; PGII; FLJ99563; Gastricsin; PEPC_HUMAN; Pepsinogen C; PGC; Progastricsin; Pepsinogen II;
PIGR
polymeric immunoglobulin receptor
PIGR; polymeric immunoglobulin receptor; poly-Ig receptor; hepatocellular carcinoma associated protein TB6; hepatocellular carcinoma-associated protein TB6; FLJ22667; MGC125361; MGC125362;
Pilra
paired immunoglobin-like type 2 receptor alpha
PILRA; paired immunoglobin-like type 2 receptor alpha; paired immunoglobulin-like type 2 receptor alpha; FDF03; Cell surface receptor FDF03; Inhibitory receptor PILR-alpha; paired immunoglobulin-like receptor alpha; PILRA_HUMAN; paired immunoglobulin-like type 2 receptor alpha; PILRA; cell surface receptor FDF03; inhibitory receptor PILR-alpha; paired immunoglobulin-like receptor alpha; paired immunoglobin-like receptor alpha; OTTHUMP00000207544; OTTHUMP00000207543; OTTHUMP00000207542; OTTHUMP00000207541; inhibitory receptor PILRalpha;
PLAT
plasminogen activator, tissue
PLAT; plasminogen activator, tissue; TPA; T-PA; DKFZp686I03148; tissue-type plasminogen activator; alteplase; reteplase; OTTHUMP00000225783; OTTHUMP00000225784; OTTHUMP00000225785; OTTHUMP00000225786; OTTHUMP00000225787; OTTHUMP00000225788; t-plasminogen activator; plasminogen activator, tissue type; tissue plasminogen activator (t-PA);
PLAU
plasminogen activator, urokinase
PLAU; PLAU plasminogen activator, urokinase; ATF; UPA; URK; u-PA urokinase-type plasminogen activator; OTTHUMP00000019849; OTTHUMP00000019850; OTTHUMP00000019851; U-plasminogen activator; plasminogen activator, urinary.;
Plaur
Plasminogen Activator, Urokinase Receptor
ATF; ATF uPA; Plasminogen activator; Plasminogen activator urinary; Plasminogen activator urokinase; PLAU; u PA; U plasminogen activator; U-plasminogen activator; UPA; URK; UROK_HUMAN; Urokinase plasminogen activator; Urokinase type plasminogen activator; Urokinase type plasminogen activator precursor; Urokinase-type plasminogen activator chain B;
SEMA3A
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
SEMA3A; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A; HH16; SemD; COLL1; SEMA1; SEMAD; SEMAL; coll-1; Hsema-I; SEMAIII; Hsema-III; semaphorin-3A; collapsin 1; semaphorin D; semaphorin L; semaphorin III;
SERPINE1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
SERPINE1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; PAI; PAI1; PAI-1; PLANH1; plasminogen activator inhibitor 1; serpin E1; endothelial plasminogen activator inhibitor; serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1;
Serpine2
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
SERPINE2; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2; PI7, serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2; glia-derived nexin; GDN; glial derived nexin 1; nexin; PN1; PNI; Glia derived nexin; Protease inhibitor 7; GDN_HUMAN; P17; Peptidase inhibitor 7; Pi-7; Plasminogen activator inhibitor type 1, member 2; PN-1; Protease nexin 1; Protease nexin I; Serpin E2; SERPINE 2; OTTHUMP00000164215; OTTHUMP00000203766; OTTHUMP00000203767; OTTHUMP00000203768; glial-derived neurite promoting factor; PI7;
Sigirr
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain
SIGIRR; single immunoglobulin and toll-interleukin 1 receptor (TIR) domain; single Ig IL-1-related receptor; single immunoglobulin domain IL1R1 related; TIR8; Single immunoglobulin domain containing IL1R related protein; Toll/interleukin 1 receptor 8; Ig IL1 related receptor; MGC110992; SIGIR_HUMAN; Single Ig IL 1 related receptor; Single Ig IL-1R-related molecule; Single Ig IL1R Related Molecule; Single immunoglobulin and toll interleukin 1 receptor (TIR) domain; Single immunoglobulin and toll interleukin 1 receptor domain; Single immunoglobulin domain-containing IL1R-related protein; TIR 8; Toll/interleukin-1 receptor 8; OTTHUMP00000229641; OTTHUMP00000229642; OTTHUMP00000229643; OTTHUMP00000229644; OTTHUMP00000229645; single immunoglobulin;
TIE1
TIE1 tyrosine kinase with immunoglobulin-like and EGF-like domains 1
TIE1; tyrosine kinase with immunoglobulin-like and EGF-like domains 1; TIE, tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 1; tyrosine-protein kinase receptor Tie-1; JTK14; tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 1; TIE;
Timd4
T-cell immunoglobulin and mucin domain containing 4
TIMD4; T-cell immunoglobulin and mucin domain containing 4; T-cell immunoglobulin and mucin domain-containing protein 4; TIM-4; TIMD-4; T-cell membrane protein 4; TIM4; SMUCKLER; FLJ27515;
UROD
uroporphyrinogen decarboxylase
UROD; uroporphyrinogen decarboxylase; uroporphyrinogen III decarboxylase; PCT; UPD;
UROS
uroporphyrinogen III synthase
UROS; uroporphyrinogen III synthase; uroporphyrinogen-III synthase; congenital erythropoietic porphyria; HEM4_HUMAN; Hydroxymethylbilane hydrolyase [cyclizing]; Hydroxymethylbilane hydrolyase; UROIIIS; Uroporphyrinogen III cosynthetase; Uroporphyrinogen III synthase (congenital erythropoietic porphyria); Uroporphyrinogen-III cosynthase; OTTHUMP00000020709; OTTHUMP00000020710; OTTHUMP00000020712;
Vsig4
V-set and immunoglobulin domain containing 4
VSIG4; V-set and immunoglobulin domain containing 4; V-set and immunoglobulin domain-containing protein 4; Z39IG; protein Z39Ig; Ig superfamily protein; complement receptor of the immunoglobulin superfamily; CRIg;
IGHE
Immunoglobulin heavy constant epsilon
immunoglobulin heavy constant epsilon; IgE; IGHE; immunoglobulin gene; IgE; Omalizumab; Xolair; 242138-07-4; Quilizumab; 1228538-47-3;
FGA
fibrinogen alpha chain
Fibrinogen; FGA; FGA protein; FGB; FGG; Fib2; Fibrinogen A alpha polypeptide; Fibrinogen A alpha polypeptide chain; Fibrinogen alpha chain; Fibrinogen B alpha polypeptide; Fibrinogen beta chain; Fibrinogen G alpha polypeptide; Fibrinogen gamma chain; MGC104327; MGC119422; MGC119423; MGC119425; MGC120405;
LRIT3
leucine-rich repeat, immunoglobulin-like and transmembrane domains 3
LRIT3; leucine-rich repeat, immunoglobulin-like and transmembrane domains 3; leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3; fibronectin type III; immunoglobulin and leucine rich repeat domains 4; FIGLER4; FLJ44691; immunoglobulin-like domain and transmembrane domain-containing protein 3; Leucine-rich repeat; leucine-rich repeat, immunoglobulin like and transmembrane domains 3; LRIT3 protein; LRIT3_HUMAN; MGC120618; OTTHUMP00000205710; fibronectin type III, immunoglobulin and leucine rich repeat domains 4;
BAG5
BCL2-associated athanogene 5
BAG5; BCL2-associated athanogene 5; BAG family molecular chaperone regulator 5; bcl-2-associated athanogene 5; BAG-family molecular chaperone regulator-5; BAG-5;
CD79A
CD79a molecule, immunoglobulin-associated alpha
CD79A; CD79a molecule, immunoglobulin-associated alpha; CD79A antigen (immunoglobulin associated alpha) , IGA; B-cell antigen receptor complex-associated protein alpha chain; MB 1; ig-alpha; MB-1 membrane glycoprotein; surface IgM-associated protein; CD79;
CD79B
CD79b molecule, immunoglobulin-associated beta
CD79B; CD79b molecule, immunoglobulin-associated beta; CD79B antigen (immunoglobulin associated beta) , IGB; B-cell antigen receptor complex-associated protein beta chain; B29; Ig-beta; B-cell-specific glycoprotein B29; immunoglobulin-associated B29 protein; CD79b antigen (immunoglobulin-associated beta); IGB; AGM6;
FGB
fibrinogen beta chain
FGB; fibrinogen beta chain; fibrinogen, B beta polypeptide; MGC104327; MGC120405;
FGL1
fibrinogen-like 1
FGL1; fibrinogen-like 1; fibrinogen-like protein 1; HFREP 1; FGL 1; FGL1_HUMAN; Fibrinogen like 1; Fibrinogen like protein 1; Fibrinogen related protein 1; Hepassocin; Hepatocellular carcinoma related sequence; Hepatocyte derived fibrinogen related protein 1; Hepatocyte-derived fibrinogen-related protein 1; HFREP-1; HFREP1; HP 041; HP-041; HP041; LFIRE 1; LFIRE-1; LFIRE1; Liver fibrinogen related protein 1; Liver fibrinogen-related protein 1; MFIRE 1; MGC108569; MGC12455; MGC37822; OTTHUMP00000122468; OTTHUMP00000224774; OTTHUMP00000224775; OTTHUMP00000224776; OTTHUMP00000224916; hepatocellular carcinoma-related sequence; hepatocyte-derived fibrinogen-related;
HYAL1
hyaluronoglucosaminidase 1
HYAL1; hyaluronoglucosaminidase 1; hyaluronidase-1; FUS2; HYAL 1; LUCA1; NAT6; Hyal-1; HYAL1_HUMAN; Hyaluronidase 1; Hyaluronoglucosaminidase-1; Hyaluronoglucosaminidase1; LUCA 1; LUCA-1; Lung carcinoma protein 1; MGC45987; Plasma hyaluronidase; Tumor suppressor LUCA 1; tumor suppressor LUCA-1;
IGDCC4
immunoglobulin superfamily, DCC subclass, member 4
IGDCC4; immunoglobulin superfamily, DCC subclass, member 4; immunoglobulin superfamily DCC subclass member 4; likely ortholog of mouse neighbor of Punc E11; LOC57722; NOPE; DDM 36; DDM36; FLJ42051; hDDM 36; hDDM36; KIAA1628; Neighbor of Punc E11; Protein DDM36; OTTHUMP00000164176;
IGFN1
immunoglobulin-like and fibronectin type III domain containing 1
IGFN1; immunoglobulin-like and fibronectin type III domain containing 1; immunoglobulin-like and fibronectin type III domain-containing protein 1; DKFZp434B1231; EEF1A2BP1; EEF1A2-binding protein 1; immunoglobulin like and fibronectin type III domain containing 1; KY interacting protein 1; eEF1A2 binding protein; KY-interacting protein 1;
IGHV4-30-1
Immunoglobulin Heavy Variable 4-30-1
IGHV4-30-1; IGHV4-3; immunoglobulin heavy variable 4-30-1;
IGSF6
immunoglobulin superfamily, member 6
immunoglobulin superfamily member 6; down-regulated by activation (immunoglobulin superfamily); IGSF6; Protein DORA; DORA; OTTHUMP00000115880; immunoglobulin superfamily, member 6;
IGSF8
immunoglobulin superfamily, member 8
IGSF8; immunoglobulin superfamily, member 8; EWI2; PGRL; CD316; EWI-2; KCT-4; CD81P3; LIR-D1; immunoglobulin superfamily member 8; CD81 partner 3; prostaglandin regulatory-like protein; glu-Trp-Ile EWI motif-containing protein 2; keratinocytes-associated transmembrane protein 4;
LILRA3
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3
LILRA3; leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3; leukocyte immunoglobulin-like receptor subfamily A member 3; CD85e; HM31; HM43; ILT6; LIR 4; LIR4; CD 85E; CD85 antigen-like family member E; CD85e antigen; e3; HM 31; HM 43; ILT 6; ILT-6; Immunoglobulin like transcript 6; Immunoglobulin-like transcript 6; Leucocyte immunoglobulin like receptor; Leukocyte immunoglobulin like receptor 4; Leukocyte immunoglobulin like receptor A3; Leukocyte immunoglobulin like receptor subfamily A (without TM domain) member 3; Leukocyte immunoglobulin like receptor subfamily A member 3; Leukocyte immunoglobulin-like receptor 4; LILRA 3; LIR-4; LIRA3_HUMAN; Monocyte inhibitory receptor HM43/HM31; OTTHUMP00000067955; OTTHUMP00000067956; OTTHUMP00000067957; leucocyte immunoglobulin-like receptor; monocyte inhibitory recept;
LILRB1
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
LILRB1; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1; leukocyte immunoglobulin-like receptor subfamily B member 1; CD85; CD85j; ILT2; LIR 1; LIR1; MIR 7; ILT-2; CD85 antigen; Ig-like transcript 2; leukocyte Ig-like receptor-1; immunoglobulin-like transcript 2; CD85 antigen-like family member J; leukocyte immunoglobulin-like receptor 1; monocyte/macrophage immunoglobulin-like receptor 7; leukocyte immunoglobulin-like receptor subfamily B member 1 soluble isoform; MIR7; LIR-1; MIR-7; FLJ37515;
LILRB2
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
LILRB2; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2; leukocyte immunoglobulin-like receptor subfamily B member 2; CD85d; ILT4; LIR 2; LIR2; MIR 10; MIR10; ILT-4; Ig-like transcript 4; immunoglobulin-like transcript 4; CD85 antigen-like family member D; leukocyte immunoglobulin-like receptor 2; monocyte/macrophage immunoglobulin-like receptor 10; leukocyte immunoglobulin-like receptor subfamily B member 2 soluble isoform; eukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6; LIR-2; LILRA6; MIR-10;
PGA3
pepsinogen 3, group I (pepsinogen A)
PGA3; pepsinogen 3, group I (pepsinogen A); pepsin A; DKFZp666J2410; pepsinogen 3 group I (pepsinogen A); Pepsinogen 3 group I; pepsinogen A3; OTTHUMP00000237816; OTTHUMP00000238421; PGA4; PGA5;
PGA5
pepsinogen 5, group I (pepsinogen A)
PGA5; pepsinogen 5, group I (pepsinogen A); pepsin A; Pepsinogen 5 group I; Pepsinogen A5; OTTHUMP00000237822; PGA3; PGA4;
PLGLB2
plasminogen-like B2
PLGLB2; plasminogen-like B2; plasminogen pseudogene 1 , PLGP1; plasminogen-related protein B; Plasminogen like B2; Plasminogen pseudogene 1; Plasminogen related protein B; PLGLB 2; PLGP 1; PLGP1; Type B plasminogen related; OTTHUMP00000160773; OTTHUMP00000203594; PLGLB1;
PPOX
protoporphyrinogen oxidase
PPOX; protoporphyrinogen oxidase; variegate porphyria , VP; PPO; VP; V290M; MGC8485;
RBPJ
recombination signal binding protein for immunoglobulin kappa J region
RBPJ; recombination signal binding protein for immunoglobulin kappa J region; SUH; csl; AOS3; CBF1; KBF2; RBP-J; RBPJK; IGKJRB; RBPSUH; IGKJRB1; recombining binding protein suppressor of hairless; CBF-1; RBP-JK; RBP-J kappa; H-2K binding factor-2; suppressor of hairless homolog; renal carcinoma antigen NY-REN-30; immunoglobulin kappa J region recombination signal binding protein 1;
SEMA4B
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B
SEMA4B; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B; SEMAC; semaphorin-4B; KIAA1745; MGC131831; SemC; Sema domain immunoglobulin domain (Ig) transmembrane domain (TM) and short cytoplasmic domain (semaphorin) 4B; Sema domain immunoglobulin domain (Ig) transmembrane domain (TM) and short cytoplasmic domain 4B; Semaphorin 4B; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4B;
SEMA4D
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
SEMA4D; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D; CD100; SEMAJ; coll-4; C9orf164; M-sema-G; semaphorin-4D; A8; GR3; BB18; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4D;
SEMA7A
sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A
SEMA7A; sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A; Semal; CDw108; H-Sema-L; M-Sema-L; 2900057C09Rik; semaphorin-7A; sema L; sema K1; H-Sema K1; semaphorin-L; Semaphorin K1; semaphorin-K1;
IGHA1
immunoglobulin alpha 1 heavy chain constant region
IGHA1; immunoglobulin alpha 1 heavy chain constant region; IgA1; FLJ14473; FLJ41548; FLJ41552; FLJ43248; FLJ43594; FLJ44293; FLJ46028; FLJ46621; FLJ46724; FLJ46811; FLJ46824; MGC102857;
IGBP1
IGBP1 immunoglobulin (CD79A) binding protein 1
IGBP1; immunoglobulin (CD79A) binding protein 1; IBP1; immunoglobulin-binding protein 1; alpha 4; protein alpha-4; CD79a-binding protein 1; renal carcinoma antigen NY-REN-16; B cell signal transduction molecule alpha 4; B-cell signal transduction molecule alpha 4; protein phosphatase 2A, regulatory subunit alpha-4; bA351K23.1 (immunoglobulin binding protein 1 (CD79A) ); ALPHA-4;
VSIG2
V-set and immunoglobulin domain containing 2
VSIG2; V-set and immunoglobulin domain containing 2; V-set and immunoglobulin domain-containing protein 2; CTH; CTXL; CT-like protein; cortical thymocyte-like protein; cortical thymocyte receptor (X. laevis CTX) like; 2210413P10Rik;
SEMA4A
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A
SEMA4A; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A; semaphorin-4A; sema B; semaphorin-B; semaphorin 4A; SemB; Semab; AI132332;
WFIKKN2
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2
WFIKKN2;WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2;WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 2;WFIKKNRP;WFIKKN-related protein;multivalent protease inhibitor protein;WAP, FS, Ig, two KU and NTR module related protein;growth and differentiation factor-associated serum protein 1;WAP, follistatin, immunoglobulin, kunitz and NTR domain-containing-related protein;GASP-1;hGASP-1;
BAG4
BCL2-associated athanogene 4
BAG4; BCL2-associated athanogene 4; BAG family molecular chaperone regulator 4; silencer of death domains; SODD; bcl-2-associated athanogene 4; BAG-family molecular chaperone regulator-4; BAG-4; DKFZp586O2022;
BAT3
BAG6 BCL2-associated athanogene 6
G3; BAT3; BAG-6; D6S52E; large proline-rich protein BAG6; scythe; protein G3; protein Scythe; OTTHUMP00000029237; OTTHUMP00000029238; OTTHUMP00000029239; HLA-B associated transcript 3; HLA-B associated transcript-3; HLA-B-associated transcript 3; large proline-rich protein BAT3; BAG family molecular chaperone regulator 6;
CTRB1
chymotrypsinogen B1
CTRB1; chymotrypsinogen B1; CTRB; chymotrypsinogen B; ChymotrypsinogenB; ChymotrypsinogenB1; CTRB 1; FLJ42412; MGC88037; OTTHUMP00000214638;
FCN3
ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen)
FCN3; ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen); ficolin-3; FCNH; HAKA1; Collagen/fibrinogen domain containing lectin 3 p35; Collagen/fibrinogen domain containing protein 3; FCN 3; Ficolin (collagen/fibrinogen domain containing) 3; Ficolin 3; H ficolin; Hakata antigen; MGC22543; H-ficolin; OTTHUMP00000006338; OTTHUMP00000006339; collagen/fibrinogen domain-containing protein 3; collagen/fibrinogen domain-containing lectin 3 p35;
HYAL3
hyaluronoglucosaminidase 3
HYAL3; hyaluronoglucosaminidase 3; hyaluronidase-3; LUCA 3; LUCA14; Minna14; Hyal-3; HYAL3_HUMAN; Hyaluronidase 3; Hyaluronoglucosaminidase-3; LUCA-3; LUCA3; Lung carcinoma protein 3; OTTHUMP00000211052; OTTHUMP00000211054; OTTHUMP00000219781;
IGHA2
Immunoglobulin heavy constant alpha 2(A2m marker)
IGHA2;Immunoglobulin heavy constant alpha 2(A2m marker);immunoglobulin heavy constant alpha 2 (A2m marker);
IGHG3
Immunoglobulin heavy constant gamma 3(G3m marker)
IGHG3; Immunoglobulin heavy constant gamma 3(G3m marker);
IGKC
immunoglobulin kappa constant
immunoglobulin light chain; Human Kappa Protein; Kappa Protein; IGKC; immunoglobulin kappa constant;
IGSF1
immunoglobulin superfamily, member 1
IGSF1; immunoglobulin superfamily, member 1; immunoglobulin superfamily member 1; IGCD1; IGDC1; INHBP; KIAA0364; MGC75490; PGSF2; Immunoglobulin like domain containing protein 1; Inhibin binding protein; p120; Pituitary gland specific factor 2; inhibin-binding protein; pituitary gland-specific factor 2; immunoglobulin-like domain-containing protein 1;
KIR2DL2
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
KIR2DL2; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2; killer cell immunoglobulin-like receptor 2DL2; CD158B1; CD158k; cl 43; nkat6; CD158 antigen-like family member B1; CD158b; KI2L2_HUMAN; MHC class I NK cell receptor; Natural killer-associated transcript 6; NKAT 6; NKAT-6; p58 natural killer cell receptor clone CL-43; p58 NK receptor CL-43; p58.2;
LILRA2
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2
LILRA2; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2; leukocyte immunoglobulin-like receptor subfamily A member 2; CD85h; ILT1; LIR 7; LIR7; CD85 antigen-like family member H; ILT-1; Immunoglobulin like transcript 1; Immunoglobulin-like transcript 1; Leukocyte immunoglobulin like receptor 7; Leukocyte immunoglobulin like receptor subfamily A member 2; Leukocyte immunoglobulin-like receptor 7; LIR-7; LIRA2_HUMAN; OTTHUMP00000068394; OTTHUMP00000068395; OTTHUMP00000068396; OTTHUMP00000068397; leuko;
OSCAR
osteoclast associated, immunoglobulin-like receptor
OSCAR; osteoclast associated, immunoglobulin-like receptor; osteoclast-associated immunoglobulin-like receptor; hOSCAR; hOSCARM2; hOSCARM3; mOSCAR; Oscar protein; OSCAR_HUMAN; OSCARS1; OSCARS2; Osteoclast associated immunoglobulin like receptor; Osteoclast associated receptor; Osteoclast-associated receptor; PIgR-3; PIGR3; Poly Ig receptor 3; Poly-Ig receptor 3; Polymeric immunoglobulin receptor 3; OTTHUMP00000067447; OTTHUMP00000067448; OTTHUMP00000067450; OTTHUMP00000067451; OTTHUMP00000067452; OTTHUMP00000067460; OTTHUMP00000081759; polymer;
SEMA4G
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G
SEMA4G; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G; semaphorin-4G; FLJ20590; KIAA1619; sema domain immunoglobulin domain (Ig) transmembrane domain (TM) and short cytoplasmic domain (semaphorin) 4G; semaphorin 4G; Semaphorin 4G precursor;
IGSF11
immunoglobulin superfamily, member 11
IGSF11; immunoglobulin superfamily, member 11; immunoglobulin superfamily member 11; BT IgSF; cancer/testis antigen 119; CT119; Igsf13; MGC35227; VSIG3; CXADR like 1; V-set and immunoglobulin domain containing 3; V-set and immunoglobulin domain-containing;
IGLC@
immunoglobulin lambda constant cluster
immunoglobulin lambda constant group; IGLC; immunoglobulin lambda constant cluster; IGLC@;
KIR3DX1
killer cell immunoglobulin-like receptor, three domains, X1
killer cell immunoglobulin-like receptor, three domains, X1; FLJ00060; KIR3DL0; LENG12; leukocyte receptor cluster (LRC) member 12; Leukocyte receptor cluster member 12; KIR3DX1;
LRIG3
leucine-rich repeats and immunoglobulin-like domains 3
LRIG3; leucine-rich repeats and immunoglobulin-like domains 3; leucine-rich repeats and immunoglobulin-like domains protein 3; FLJ90440; KIAA3016; LIG3; LRIG1-3; LIG-3; OTTHUMP00000242498; OTTHUMP00000242499; OTTHUMP00000242500;
TMIGD1
transmembrane and immunoglobulin domain containing 1
TMIGD1;transmembrane and immunoglobulin domain containing 1;TMIGD;transmembrane and immunoglobulin domain-containing protein 1;UNQ9372;AWKS9372;
FCN2
ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin)
FCN2; ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin); ficolin-2; collagen/fibrinogen domain containing protein 2; EBP 37; FCNL; ficolin B; ficolin 2; hucolin; L ficolin; P35; serum lectin p35; 37 kDa elastin-binding protein; Ficolin beta; OTTHUMP00000022518; RP11-263F14.2; L-ficolin; ficolin-B; ficolin-beta; collagen/fibrinogen domain-containing protein 2; EBP-37;
IGJ
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides
IGJ; immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides; immunoglobulin J chain; IGCJ; JCH; IGJ_HUMAN; Immunoglobulin J polypeptide linker protein for immunoglobulin alpha and mu polypeptides; OTTHUMP00000160357; OTTHUMP00000219133; OTTHUMP00000219134; OTTHUMP00000219135;
LILRA4
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4
LILRA4; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4; leukocyte immunoglobulin-like receptor subfamily A member 4; CD85g; ILT7; ILT-7; OTTHUMP00000067952; immunoglobulin-like transcript 7; CD85 antigen-like family member G; leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 4;
TIMD2
T-cell immunoglobulin and mucin domain containing 2
TIMD2; T-cell immunoglobulin and mucin domain containing 2; T-cell immunoglobulin and mucin domain-containing protein 2; T cell immunoglobulin and mucin domain containing 2 protein; Tim2; TIMD-2; OTTMUSP00000005656; OTTMUSP00000005657; T-cell membrane protein 2; G9D3; TIM-2; C78111; AA816106; AU019358; AU019662;
VSIG1
V-set and immunoglobulin domain containing 1
1700062D20Rik; Cell surface A33 antigen; ChT1 thymocyte antigen; dJ889N15.1; Glycoprotein A34; GPA34; MGC44287; OTTHUMP00000023820; V set and immunoglobulin domain containing; V-set and immunoglobulin domain containing 1; V-set and immunoglobulin domain-containing protein 1; VSIG1; VSIG1_HUMAN;
WFIKKN1
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1
WFIKKN1; WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1; C16orf12, chromosome 16 open reading frame 12; WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1; RJD2; WFIKKN; C16orf12; Chromosome 16 open reading frame 12; GASP 2; GASP2; Growth and differentiation factor-associated serum protein; hGASP 2; WAP, follistatin/kazal, immunoglobulin, kunitz and netrin; WAP, FS, Ig, KU, and NTR containing protein; GASP-2; hGASP-2; OTTHUMP00000115417; WAP, FS, Ig, KU, and NTR-containing protein; growth and differentiation factor-associated serum protein 2; WAP, follistatin, immunoglobulin, kunitz and;
IGHD
Immunoglobulin heavy constant delta
IGHD;Immunoglobulin heavy constant delta;immunoglobulin heavy constant delta;FLJ00382;FLJ46727;MGC29633;
IGHG2
Immunoglobulin heavy constant gamma 2 (G2m marker)
DKFZp686I04196; G2m marker; Ig gamma 2 chain C region; IGHG 2; IGHG2; Immunoglobulin heavy constant gamma 2; Immunoglobulin G 2; IgG2;
Ighg2a
immunoglobulin heavy constant gamma 2A
Igh-1; Igh-1a; MGC18977; MGC102662; MGC118125; 1810060O09Rik; Ighg2a;
IGHG4
Immunoglobulin Heavy Constant Gamma 3 (G4m Marker)
IgG4; Immunoglobulin G; IGG; Immunoglobulin; IGHG4; immunoglobulin heavy constant gamma 4 (G4m marker); Alternative namesIg gamma 4 chain C region; MGC117419; Ig gamma-4 chain C region;
PGA
pepsinogen A
PGA; pepsinogen A; pepsin A; ec 3.4.23.1; Pepsin a precursor; Pepsin; Pepsinogen 1 second locus; Pepsinogen 3 group 1; Pepsinogen a3; Pepsinogen; Pepsinogen group 1; pga3; pga4; pga5;
AGPHD1
aminoglycoside phosphotransferase domain containing 1
AGPHD1; aminoglycoside phosphotransferase domain containing 1; aminoglycoside phosphotransferase domain-containing protein 1; LOC123688; AGPD1_HUMAN; Aminoglycoside phosphotransferase domain containing; C630028N24Rik; OTTMUSP00000025874; RGD1308677;
MUG1
murinoglobulin 1
MUG1; murinoglobulin 1; murinoglobulin-1; alpha(1)-inhibitor 3; alpha-1-inhibitor III; Murinoglobulin 1 homolog; plasma proteinase inhibitor; alpha-X protein; alpha-1 inhibitor 3 variant I; plasma proteinase inhibitor alpha-1-inhibitor III;
BAG6
BCL2-associated athanogene 6
BAG6; BCL2-associated athanogene 6; BAT3, HLA B associated transcript 3; large proline-rich protein BAG6; D6S52E; G3; scythe; protein G3; protein Scythe; HLA-B associated transcript 3; HLA-B associated transcript-3; HLA-B-associated transcript 3; large p;
BIVM
basic, immunoglobulin-like variable motif containing
BIVM; basic, immunoglobulin-like variable motif containing; basic immunoglobulin-like variable motif-containing protein; FLJ20159; AI854267; FLJ44301; Basic immunoglobulin like variable motif containing; FLJ44556; MGC133326; OTTMUSP00000026562; OTTMUSP00000026563; RP11-484I6.1;
CPOX
coproporphyrinogen oxidase
CPOX; coproporphyrinogen oxidase; coproporphyrinogen oxidase (coproporphyria, harderoporphyria) , CPO; coproporphyrinogen-III oxidase, mitochondrial; coproporphyria; CPX; HCP; COX; coprogen oxidase; coproporphyrinogenase; CPO;
HYAL4
hyaluronoglucosaminidase 4
HYAL4; hyaluronoglucosaminidase 4; hyaluronidase-4; hyaluronidase 4; chondroitin sulfate hydrolase; CSHY; Hyal-4; HYAL4_HUMAN; Hyaluronoglucosaminidase-4;
ISLR2
immunoglobulin superfamily containing leucine-rich repeat 2
ISLR2; immunoglobulin superfamily containing leucine-rich repeat 2; immunoglobulin superfamily containing leucine-rich repeat protein 2; leucine-rich repeat domain and immunoglobulin domain containing axon extension protein; leucine-rich repeat domain and;
IGLL1
immunoglobulin lambda-like polypeptide 1
IGLL1; immunoglobulin lambda-like polypeptide 1; lambda 5; ig lambda-5; immunoglobulin lambda chain 5; CD179 antigen-like family member B; Igll; Igl-5; Lambda5; BB139905;
HYAL2
hyaluronoglucosaminidase 2
HYAL2; hyaluronoglucosaminidase 2; LUCA2; hyaluronidase-2; hyal-2; PH20 homolog; PH-20 homolog; hyaluronidase 2; lysosomal hyaluronidase; lung carcinoma protein 2; hyaluronoglucosaminidase-2;
KIR2DS1
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
KIR2DS1; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1; killer cell immunoglobulin-like receptor 2DS1; CD158H; EB6ActI; EB6ActII; p50.1; CD158 antigen-like family member H; CD158a; KI2S1_HUMAN; MHC class I NK cell receptor Eb6 ActI; XXbac-BCX195L8.7; KIR2DL1-KIR2DS1; killer-cell immunoglobulin-like receptor; killer cell immunoglobulin-like receptor KIRDS1;
ILDR1
immunoglobulin-like domain containing receptor 1
ILDR1; immunoglobulin-like domain containing receptor 1; deafness, autosomal recessive 42 , DFNB42; immunoglobulin-like domain-containing receptor 1; MGC50831; ILDR1alpha; ILDR1beta; Immunoglobulin like domain containing receptor 1 alpha; Immunoglobulin like domain containing receptor 1; Immunoglobulin like domain containing receptor 1 beta; OTTHUMP00000215507; OTTHUMP00000215508; OTTHUMP00000215509; OTTHUMP00000215510; immunoglobulin-like domain-containing receptor 1 beta; immunoglobulin-like domain-containing receptor 1 alpha; DFNB42;
IGSF21
immunoglobin superfamily, member 21
IGSF21; immunoglobin superfamily, member 21; immunoglobulin superfamily member 21; MGC15730; RP11 121A23.1; FLJ41177; IGSF 21; Immunoglobin superfamily member 21;
IGSF5
immunoglobulin superfamily, member 5
IGSF5; immunoglobulin superfamily, member 5; immunoglobulin superfamily member 5; JAM4; junctional adhesion molecule 4; GSF5; IGSF5_HUMAN; Immunoglobulin superfamily 5 like; JAM-4;
LILRA5
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5
LILRA5; leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5; LILRB7; leukocyte immunoglobulin-like receptor subfamily A member 5; CD85; CD85f; ILT11; LIR9; CD85 antigen-like family member F; ILT-11; Immunoglobulin like transcript 11 protein; Immunoglobulin-like transcript 11; Leukocyte Ig like receptor 9; Leukocyte immunoglobulin like receptor subfamily A (with TM domain) member 5; Leukocyte immunoglobulin-like receptor 9; Leukocyte immunoglobulin-like receptor subfamily B (with TM and ITIM domains) member 7; LIR-9; LIRA5_HUMAN; leukocyte Ig-like receptor 9; immunoglobulin-like transcript 11 protein; leukocyte immunoglobulin-like receptor subfamily A member 5 soluble; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 7;
KIR2DS2
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
KIR2DL+KIR2DS1+KIR2DS2; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2; KIR2DS2; killer cell immunoglobulin-like receptor 2DS2; 183ActI; CD158J; cl 49; nkat5; NKAT-5; p58 KIR; 1060P11.9.2; NK receptor 183 ActI; p58 NK receptor CL-49; MHC class I;
KIR2DS5
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
KIR2DS5; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5; killer cell immunoglobulin-like receptor 2DS5; CD158G; nkat9; CD158 antigen like family member G; Flags: Precursor; Killer cell immunoglobulin like receptor 2DS5; Killer cell immunoglobulin like receptor two domains short cytoplasmic tail 5; MHC class I NK cell receptor; Natural killer associated transcript 9; Natural killer cell inhibitory receptor; NKAT 9; NKAT-9; CD158 antigen-like family member G; natural killer-associated transcript 9;
KIR3DL2
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
KIR3DL2; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2; killer cell immunoglobulin-like receptor 3DL2; CD158K; cl 5; nkat4; nkat4a; nkat4b; CD158 antigen like family member K; CD158 antigen-like family member K; KI3L2_HUMAN; Killer cell immunoglobulin like receptor 3DL2; killer cell immunoglobulin like receptor KIR3DL2; Killer cell immunoglobulin like receptor, three domains, long cytoplasmic tail, 2; KIR antigen 3DL2; Kirl2; MHC class I NK cell receptor; Natural killer associated transcript 4; natural killer cell inhibitory receptor; Natural killer-associated transcript 4; NK associated transcript 4; NK associated transcript 4A, included; NK associated transcript 4B, included; NKAT-4; p140; p70 natural killer cell receptor clone CL 5; p70 natural killer cell receptor clone CL-5; p70 NK receptor CL 5; p70 NK receptor CL-5; killer Ig receptor; p70 killer cell inhibitory receptor; killer cell immunoglobulin-like receptor KIR3DL2;
LOC727787
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like
LOC727787; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like; Killer cell immunoglobulin like receptor three domains long cytoplasmic tail 2 like; LOC727787|-|-;
LRIG1
leucine-rich repeats and immunoglobulin-like domains 1
LRIG1; leucine-rich repeats and immunoglobulin-like domains 1; leucine-rich repeats and immunoglobulin-like domains protein 1; DKFZP586O1624; leucine rich repeat protein LRIG1; LIG 1; LIG1; ortholog of mouse integral membrane glycoprotein LIG 1; Leucine rich repeat protein; leucine rich repeats and immunoglobulin like domains 1; LIG-1; LRIG1_HUMAN; OTTHUMP00000213345; OTTHUMP00000213346; leucine-rich repeat protein LRIG1; ortholog of mouse integral membrane glycoprotein LIG-1;
PVRIG
poliovirus receptor related immunoglobulin domain containing
PVRIG; poliovirus receptor related immunoglobulin domain containing; transmembrane protein PVRIG; C7orf15; MGC2463; Poliovirus receptor-related immunoglobulin domain-containing protein; PVRIG_HUMAN;
PILRB
paired immunoglobin-like type 2 receptor beta
PILRB; paired immunoglobin-like type 2 receptor beta; paired immunoglobulin-like type 2 receptor beta; FDFACT1; FDFACT2; activating receptor PILRbeta; cell surface receptor FDFACT; activating receptor PILR-beta; cell surface receptor FDFACT1; cell surface;
SEMA3E
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
SEMA3E; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E; SEMAH; semaphorin-3E; coll 5; KIAA0331; M sema H; M SemaK; coll-5; M-SEMAH; M-SemaK;
SEMA3F
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
SEMA3F; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F; SEMA4; SEMAK; SEMA-IV; semaphorin-3F; sema IV; sema III/F; semaphorin IV; semaphorin III/F; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, 3F;
SEMA3G
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G
SEMA3G; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G; semaphorin-3G; FLJ00014; sem2; MGC119473; Sema domain immunoglobulin domain (Ig) short basic domain secreted (semaphorin) 3G; Semaphorin 3G; Semaphorin sem2;
SEMA3B
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
SEMA3B; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B; SemA; SEMA5; SEMAA; semaV; LUCA-1; semaphorin-3B; sema A(V); semaphorin A; semaphorin-V;
SEMA3D
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D
SEMA3D; sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D; coll-2; Sema-Z2; semaphorin-3D; collapsin 2;
SEMG1
semenogelin I
SEMG1; semenogelin I; SEMG; semenogelin-1; cancer/testis antigen 103; CT103; semen coagulating protein; SGI; dJ172H20.2; FLJ78262; MGC14719;
IGHMBP2
immunoglobulin mu binding protein 2
IGHMBP2; immunoglobulin mu binding protein 2; DNA-binding protein SMUBP-2; cardiac transcription factor 1; CATF1; HCSA; HMN6; SMARD1; SMUBP2; GF-1; glial factor 1; ATP-dependent helicase IGHMBP2; immunoglobulin mu-binding protein 2; FLJ34220; FLJ41171;
IGSF3
immunoglobulin superfamily, member 3
IGSF3; immunoglobulin superfamily, member 3; immunoglobulin superfamily member 3; EWI 3; MGC117164; V8; immunoglobin superfamily, member 3; glu-Trp-Ile EWI motif-containing protein 3; EWI-3;
SEMA4F
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F
SEMA4F; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F; SEMAM; semaphorin-4F; m Sema M; SEMAW; M SEMA; PRO2353; Sema domain immunoglobulin domain (Ig) transmembrane; Sema M; Sema W; Semaphorin M; Semaphorin W; semaphorin-M; semaphorin-W; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4F; M-SEMA; m-Sema-M;
KIR2DL5A
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
KIR2DL5A; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A; CD158F; KIR2DL5; KIR2DL5.1;
KIR3DS1
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
KIR3DS1;killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1;killer cell immunoglobulin-like receptor 3DS1;nkat10;NKAT-10;killer Ig receptor;MHC class I NK cell receptor;natural killer-associated transcript 10;killer cell immunoglobulin-like receptor KIR3DS1;KIR-G1;NKAT10;CD158E2;KIR-123FM;MGC119726;MGC119728;MGC125316;
IgG
Immunoglobulin G
IgG; Immunoglobulin G; Llama IgG; Llama; Ig gamma 1 chain C region; IGHG1; Immunoglobin heavy constant gamma 1; Immunoglobulin G;
LILRB4
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
LILRB4;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4;6608;ENSG00000186818;HM18;ILT3;LIR5;CD85K;LIR-5;LILRB5;19q13.4;leukocyte immunoglobulin-like receptor subfamily B member 4;leukocyte immunoglobulin-like receptor subfamily B member 4;ILT-3;immunoglobulin-like transcript 3;CD85 antigen-like family member K;monocyte inhibitory receptor HM18;leukocyte immunoglobulin-like receptor 5;leukocyte immunoglobulin-like receptor, subfamily B, member 4;leukocyte immunoglobulin-like receptor subfamily B member 4 soluble isoform;
VSIG10
V-set and immunoglobulin domain containing 10
VSIG10;V-set and immunoglobulin domain containing 10;26078;ENSG00000176834;12q24.23;MGC1013, FLJ20674;V-set and immunoglobulin domain-containing protein 10;V-set and immunoglobulin domain-containing protein 10;
IGDCC3
immunoglobulin superfamily, DCC subclass, member 3
IGDCC3;immunoglobulin superfamily, DCC subclass, member 3;9700;ENSG00000174498;PUNC;HsT18880;15q22.3-q23;immunoglobulin superfamily DCC subclass member 3;immunoglobulin superfamily DCC subclass member 3;putative neuronal cell adhesion molecule;
IGSF9B
immunoglobulin superfamily, member 9B
IGSF9B;immunoglobulin superfamily, member 9B;32326;ENSG00000080854;11q25;KIAA1030;protein turtle homolog B;protein turtle homolog B;immunoglobulin superfamily member 9B;
IGSF9
immunoglobulin superfamily, member 9
IGSF9;immunoglobulin superfamily, member 9;18132;ENSG00000085552;Nrt1;IGSF9A;FP18798;1q22-q23;KIAA1355;protein turtle homolog A;protein turtle homolog A;immunoglobulin superfamily member 9A;
ILDR2
immunoglobulin-like domain containing receptor 2
ILDR2;immunoglobulin-like domain containing receptor 2;18131;ENSG00000143195;C1orf32;dJ782G3.1;RP4-782G3.2;1q24.1;immunoglobulin-like domain-containing receptor 2;immunoglobulin-like domain-containing receptor 2;
LILRB5
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 [ Homo sap
LILRB5;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5;6609;ENSG00000105609;LIR8;CD85C;LIR-8;19q13.4;leukocyte immunoglobulin-like receptor subfamily B member 5;leukocyte immunoglobulin-like receptor subfamily B member 5;CD85 antigen-like family member C;leukocyte immunoglobulin-like receptor 8;
LRIT1
leucine-rich repeat, immunoglobulin-like and transmembrane domains 1
LRIT1;leucine-rich repeat, immunoglobulin-like and transmembrane domains 1;23404;ENSG00000148602;PAL;LRRC21;FIGLER9;10q23;DKFZp434K091;leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1;leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1;retina-specific protein PAL;leucine rich repeat containing 21;leucine-rich repeat-containing protein 21;photoreceptor-associated LRR superfamily protein;fibronectin type III, immunoglobulin and leucine rich repeat domains 9;
LRIG2
leucine-rich repeats and immunoglobulin-like domains 2
LRIG2;leucine-rich repeats and immunoglobulin-like domains 2;20889;ENSG00000198799;LIG2;LIG-2;1p13.1;KIAA0806, DKFZp451C181;leucine-rich repeats and immunoglobulin-like domains protein 2;leucine-rich repeats and immunoglobulin-like domains protein 2;
LRIT2
leucine-rich repeat, immunoglobulin-like and transmembrane domains 2
LRIT2;leucine-rich repeat, immunoglobulin-like and transmembrane domains 2;23443;ENSG00000204033;LRRC22;10q23.1;leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2;leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2;leucine rich repeat containing 22;leucine-rich repeat-containing protein 22;
SEMA3C
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C [ Homo sapie
SEMA3C;sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C;10725;ENSG00000075223;SemE;SEMAE;7q21-q31;semaphorin-3C;semaphorin-3C;sema E;semaphorin E;semaphorin-E;
SEMA4C
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (s
SEMA4C;sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C;10731;ENSG00000168758;SEMAF;SEMAI;SEMACL1;M-SEMA-F;2q11.2;FLJ20369, KIAA1739, MGC126382, MGC126383;semaphorin-4C;semaphorin-4C;M-Sema F;
TMIGD2
transmembrane and immunoglobulin domain containing 2
TMIGD2;transmembrane and immunoglobulin domain containing 2;28324;ENSG00000167664;IGPR1;IGPR-1;19p13.3;MGC23244;transmembrane and immunoglobulin domain-containing protein 2;transmembrane and immunoglobulin domain-containing protein 2;immunoglobulin-containing and proline-rich receptor 1;transmembrane and immunoglobulin domain-containing protein 2 variant 2;transmembrane and immunoglobulin domain-containing protein 2 variant 3;
IGSF22
immunoglobulin superfamily, member 22
IGSF22;immunoglobulin superfamily, member 22;26750;ENSG00000179057;11p15.1;FLJ37794;immunoglobulin superfamily member 22;immunoglobulin superfamily member 22;
PLGRKT
plasminogen receptor, C-terminal lysine transmembrane protein
PLGRKT;plasminogen receptor, C-terminal lysine transmembrane protein;23633;ENSG00000107020;AD025;MDS030;C9orf46;PLG-RKT;Plg-R(KT);9p24.1;FLJ14688, FLJ39176;plasminogen receptor (KT);plasminogen receptor (KT);5033414D02Rik;transmembrane protein C9orf46;plasminogen receptor with a C-terminal lysine;
ISLR
immunoglobulin superfamily containing leucine-rich repeat
ISLR;immunoglobulin superfamily containing leucine-rich repeat;6133;ENSG00000129009;HsT17563;15q23-q24;MGC102816;immunoglobulin superfamily containing leucine-rich repeat protein;immunoglobulin superfamily containing leucine-rich repeat protein;
KIR3DL3
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3
KIR44; KIRC1; CD158Z; KIR3DL7;
LILRA6
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6
ILT5; ILT8; CD85b; LILRB3; LILRB6;
Lilrb3l
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3-like
Pirb; Lilrb3; Pir-A1; Pir-A2;
VSIG8
V-set and immunoglobulin domain containing 8
VSIG8; V-set and immunoglobulin domain containing 8;
Fibcd1
FIBCD1 fibrinogen C domain containing 1 [ Homo sapiens ]
fibrinogen C domain containing 1; 25922; Ensembl:ENSG00000130720; FLJ14810; fibrinogen C domain-containing protein 1;
Rbpjl
recombination signal binding protein for immunoglobulin kappa J region-like
RBPJL; SUHL; RBPSUHL; recombination signal binding protein for immunoglobulin kappa J region-like; recombining binding protein suppressor of hairless-like protein; transcription factor RBP-L;
SERPINE3
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 3
vnc
vnc variable nurse cells [ Drosophila melanogaster (fruit fly) ]
ard1; CG11989; dArd1; DmAAF50178; Dmel\CG11989; Dromel_CG11989_FBtr0076348_ard1_mORF; l(3)67BDk; vnc Ard1; CG11989-PA; CG11989-PB; CG11989-PC; CG11989-PD; CG11989-PE; arrest defective 1; arrest defective1; lethal (3) 67BDk; variable nurse cell; variable nurse cells; vnc-PA; vnc-PB; vnc-PC; vnc-PD; vnc-PE;
IGKV1-5
IGKV1-5?immunoglobulin kappa variable 1-5 [?Homo sapiens?(human) ]
V1; L12; IGKV; L12a; IGKV15; IGKV1-5; immunoglobulin kappa variable 1-5;
IGLV6-57
IGLV6-57 immunoglobulin lambda variable 6-57 [ Homo sapiens (human) ]
immunoglobulin lambda variable 6-57; IGLV657; V1-22;
